MyAverix Finance
NS · Pharmaceuticals
NGL Fine-Chem Ltd (NGLFINE)
Pharmaceuticals & Biotechnology
NGL Fine-Chem Ltd (NGLFINE) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $19.04B, P/E ratio is 45.73, net margin is 8.1%, dividend yield is 0.06%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NGLFINE
NGL Fine-Chem Ltd (NGLFINE) — FAQ
What is NGL Fine-Chem Ltd's market cap?
NGL Fine-Chem Ltd (NGLFINE) has a reported market cap of $19.04B (data as of 2026-07-10).
What is NGLFINE's P/E ratio?
The price-to-earnings (P/E) ratio for NGL Fine-Chem Ltd (NGLFINE) is 45.73 (data as of 2026-07-10).
Does NGL Fine-Chem Ltd pay a dividend?
NGL Fine-Chem Ltd (NGLFINE) shows a reported dividend yield of 0.06%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is NGL Fine-Chem Ltd in?
NGL Fine-Chem Ltd (NGLFINE) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is NGLFINE listed on?
NGLFINE is listed on NS.
What is NGL Fine-Chem Ltd's net margin?
NGL Fine-Chem Ltd (NGLFINE) reports a net margin of 8.1% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.